Anavex Life Sciences (GB:0HFR)
LSE:0HFR

Anavex Life Sciences (0HFR) Share Price & Analysis

0 Followers

0HFR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$7.61 - $14.80
Previous Close$9.15
Volume1.93K
Average Volume (3M)2.49K
Market Cap
$746.94M
Enterprise Value$593.47M
Total Cash (Recent Filing)$153.47M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-13.5
Beta0.62
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.68
Shares Outstanding80,837,723
10 Day Avg. Volume116
30 Day Avg. Volume2,494
Standard Deviation0.26
R-Squared0.02
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)5.61
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-32.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-10.40
Forecast
Price Target Upside391.80% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4


Financials

Annual

0HFR FAQ

What was Anavex Life Sciences’s price range in the past 12 months?
Anavex Life Sciences lowest share price was $7.61 and its highest was $14.79 in the past 12 months.
    What is Anavex Life Sciences’s market cap?
    Currently, no data Available
    When is Anavex Life Sciences’s upcoming earnings report date?
    Anavex Life Sciences’s upcoming earnings report date is Aug 10, 2023 which is in 61 days.
      How were Anavex Life Sciences’s earnings last quarter?
      Anavex Life Sciences released its earnings results on May 09, 2023. The company reported -$0.17 earnings per share for the quarter, beating the consensus estimate of -$0.188 by $0.018.
        Is Anavex Life Sciences overvalued?
        According to Wall Street analysts Anavex Life Sciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Anavex Life Sciences pay dividends?
          Anavex Life Sciences does not currently pay dividends.
          What is Anavex Life Sciences’s EPS estimate?
          Anavex Life Sciences’s EPS estimate is -$0.18.
            How many shares outstanding does Anavex Life Sciences have?
            Anavex Life Sciences has 80,837,720 shares outstanding.
              What happened to Anavex Life Sciences’s price movement after its last earnings report?
              Anavex Life Sciences reported an EPS of -$0.17 in its last earnings report, beating expectations of -$0.188. Following the earnings report the stock price went up 6.641%.
                Which hedge fund is a major shareholder of Anavex Life Sciences?
                Among the largest hedge funds holding Anavex Life Sciences’s share is Sheaff Brock Investment Advisors LLC. It holds Anavex Life Sciences’s shares valued at 186K.

                  ---

                  Anavex Life Sciences Stock Smart Score

                  The Anavex Life Sciences Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Anavex Life Sciences

                  Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Anavex Life Sciences
                  Axsome Therapeutics
                  Kala Pharmaceuticals
                  Insmed
                  Amicus

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis